Best Supplements for Improved Blood Lipid Profile
Ranked by research evidence. Compare 72 supplements across 89 papers from the biomedical literature, with effect direction, evidence strength, and dose range for each.
Top picks by evidence
- Low evidence3 studies
Across 3 studies, all reported beneficial effects of Lactobacillus reuteri NCIMB 30242 on blood lipid profiles, but only one was a randomized controlled trial showing a small effect size with statistically significant reductions in LDL-C/HDL-C ratio and apoB-100/apoA-1 ratio. The most studied population is hypercholesterolemic adults, and no consistent dose range was reported. The evidence base is too small to draw firm conclusions.
Product matchLife Extension — FLORASSIST Probiotic Heart Health2,500,000,000 CFU · $23.99 · ★4.6 (406) - Low evidence3 studies
Across 3 studies, 2 reported small beneficial effects and 1 reported a neutral effect, with 2 of 3 reaching statistical significance. The predominant effect size is small. Median study duration across the one study reporting duration was 112 days (16 weeks). The evidence base is too small to determine a most-studied dose or population with confidence.
Product matchViva Naturals — Vitamin D3 with Organic Liquid Coconut Oil125 mcg · $15.16 · ★5.0 (208)
- LowLactobacillus reuteri NCIMB 30242Across 3 studies, all reported beneficial effects of Lactobacillus reuteri NCIMB 30242 on blood lipid profiles, but only one was a randomized controlled trial showing a small effect size with statistically significant reductions in LDL-C/HDL-C ratio and apoB-100/apoA-1 ratio. The most studied population is hypercholesterolemic adults, and no consistent dose range was reported. The evidence base is too small to draw firm conclusions.3 beneficial3 studies
- LowVitamin DAcross 3 studies, 2 reported small beneficial effects and 1 reported a neutral effect, with 2 of 3 reaching statistical significance. The predominant effect size is small. Median study duration across the one study reporting duration was 112 days (16 weeks). The evidence base is too small to determine a most-studied dose or population with confidence.2 beneficial1 neutral3 studies